Updates in the Treatment of Secondary AML After the 2024 SOHO Annual Meeting - Episode 3

Long-Term Data for CPX-351 in Secondary AML

,

James K. McCluskey, MD, and Harry P. Erba, MD, PhD, discuss long-term data for CPX-351 in acute myeloid leukemia.